For pediatric patients with Crohn disease, early anti-tumor necrosis factor-alpha (anti-TNFα) therapy is beneficial in ...

Intestinal ultrasound (IU) can be considered a screening tool for pediatric inflammatory bowel disease (IBD), according to a ...

A new quick-and-easy nasal swab test for kids can diagnose the specific immune system drivers behind their asthma, ...

Large numbers of Australians are turning to surgery to screen for gastrointestinal diseases, as a major health insurer ...

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...

MetroCreative Inflammatory bowel disease (IBD) affects between 2.4 and 3.1 million people across the United States, according ...

For many people with Crohn’s disease, reaching remission—when inflammation is no longer detectable—seems like a major victory ...

RG-6631 is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Crohn's Disease (Regional Enteritis).

Lutikizumab is under clinical development by AbbVie and currently in Phase II for Crohn's Disease (Regional Enteritis).

Steqeyma is approved for adult and pediatric patients with plaque psoriasis and active psoriatic arthritis as well as adults ...

is rummy legal in india Overview of clinical developments of China's Class 1 new drugs in March 2020 Takeda Pharmaceuticals' Vedolizumab is close to approval for the treatment of ulcerative colitis ...

By trawling through databases of RNA sequences based on models of intestinal damage, a team of researchers led by scientists ...